Interesting case study Highlights: ABSTRACT A healthy, fit 61-year old male endurance athlete received four (4 each) intravenous glutathione treatments consisting of 100 mg/cc, using 10cc (total 1000 milligrams) diluted total of 20cc normal saline solution slow IV-push delivery (15 minutes)
The results showed that in high risk patients with T2D liraglutide reduced the risk of MACE by 13% (primary endpoint included cardiovascular death, non-fatal myocardial infarction (MI), and non-fatal stroke) ( In the ELIXA and the EXSCEL trials, GLP-1RAs (once daily lixisenatide and once weekly exenatide, respectively) didnt provide benefit in MACE reduction compared to placebo, but were non-inferior to placebo for the primary composite outcome of MACE
Hydration Power : Combined with saline and electrolytes like sodium and potassium, it hydrates you while sending Glutathione to your cells
Alcohol, environmental toxins, chronic stress, poor sleep, processed food
MT-2 acts as a non-selective agonist across the melanocortin receptor family (MC1R through MC5R)
Are there initial microbiome compositions that are more sensitive to SGA treatment and therefore predict enhanced weight-gain